MethodsRetrospective case series of patients with CT diagnosed brain metastases at a single institution between 1983 and 1998.
Participants and Country122 patients with brain metastases of unknown primary. Switzerland (220 patients with known primary tumours were included for comparison).
InterventionsSurgery plus WBRT (46/122, 38%), radiosurgery plus WBRT (4/122, 3%), WBRT only (45/122, 37%), or corticosteroids (27/122, 22%).
OutcomesNot reported
WBRT fractionationOverall survival

From: Guideline chapter 4, Specific Presentations

Cover of Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin
Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin.
NICE Clinical Guidelines, No. 104.
National Collaborating Centre for Cancer (UK).
Copyright © 2010, National Collaborating Centre for Cancer.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licenses issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.